Abstract

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension

Author(s): Davidson Michael G

Issue: Mar/Apr 2001 - Compounding for Animals

Page(s): 92-94

Download in electronic PDF format for $75

Abstract

The purpose of this article is to provide the compounding pharmacist with an overview of two ocular diseases that commonly affect cats and to describe the medications used in therapy. The author discusses feline herpesvirus-1 and systemic hypertension. A table provides selected drug therapies for feline conjunctivitis and keratitis, and a sidebar provides information regarding quinolone-induced blindness. In summary, four of the seven therapies for treating feline herpesvirus-related conjunctivitis and keratitis are commercially unavailable; and the therapy for feline hypertension is appropriate only for human dosing, so compounded dosage forms must often be used. Understanding ocular pharmacology and the underlying causes of feline ophthalmic disease can help the compounding pharmacist become integrally involved in feline care and can contribute to positive therapeutic outcomes and an increased quality of life for the patient.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2001 Pg. 92-94	Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Author(s): Davidson Michael G
Nov/Dec 2010 Pg. 488-491	Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Author(s): Rudner Shara, Browne Paul
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Nov/Dec 2006 Pg. 411-414	Compounding for Feline Herpetic Keratitis Author(s): Davidson Gigi S
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
May/Jun 2004 Pg. 169-172	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Author(s): Davidson Gigi S
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
May/Jun 2012 Pg. 190-195	I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Author(s): McElhiney Linda F
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Jan/Feb 2007 Pg. 44-48	Psychotropic Medications in the Treatment of Feline Urine Spraying Author(s): Simpson Barbara Sherman, Vail Jane
Sep/Oct 2003 Pg. 345-347	Understanding Feline Hyperthyroidism Author(s): Davidson Gigi S
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Jul/Aug 2004 Pg. 277-283	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Author(s): Davidson Gigi S
Sep/Oct 2004 Pg. 359-367	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Author(s): Davidson Gigi S
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 382-394	Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists Author(s): Meadows Richard L, Muller George
Mar/Apr 2010 Pg. 108-111	Coenzyme Q10 Supplementation in the Treatment of Heart Disease Author(s): Bramwell Bethany L
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr